| Schedule of Basic and Diluted Net Income (Loss) Per Share |
Schedule
of Basic and Diluted Net Income (Loss) Per Share
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| |
|
Three
Months Ended March 31, |
|
|
Six
Months Ended March 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net
(loss) income |
|
$ |
(3,491,122 |
) |
|
$ |
365,425 |
|
|
$ |
(6,651,828 |
) |
|
$ |
(803,084 |
) |
| Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted
average shares outstanding, basic |
|
|
3,921,641 |
|
|
|
577,374 |
|
|
|
2,961,796 |
|
|
|
525,756 |
|
| Restricted
stock units and awards |
|
|
— |
|
|
|
1,389 |
|
|
|
— |
|
|
|
— |
|
| Warrants |
|
|
— |
|
|
|
32,128 |
|
|
|
— |
|
|
|
— |
|
| Weighted
average shares outstanding, diluted |
|
|
3,921,641 |
|
|
|
610,891 |
|
|
|
2,961,796 |
|
|
|
525,756 |
|
| Net
(loss) income per share, basic |
|
$ |
(0.89 |
) |
|
$ |
0.63 |
|
|
$ |
(2.25 |
) |
|
$ |
(1.53 |
) |
| Net
(loss) income per share, diluted |
|
$ |
(0.89 |
) |
|
$ |
0.60 |
|
|
$ |
(2.25 |
) |
|
$ |
(1.53 |
) |
|
| Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Shares |
The
following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they
would be anti-dilutive:
Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Shares
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| |
|
Three
Months Ended March 31, |
|
|
Six
Months Ended March 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Common
stock warrants August 2021 |
|
|
14,031 |
|
|
|
14,031 |
|
|
|
14,031 |
|
|
|
14,031 |
|
| Underwriter
warrants August 2021 |
|
|
284 |
|
|
|
284 |
|
|
|
284 |
|
|
|
284 |
|
| Chanticleer
warrants |
|
|
6 |
|
|
|
6 |
|
|
|
6 |
|
|
|
6 |
|
| Series
C warrants |
|
|
2,297 |
|
|
|
2,297 |
|
|
|
2,297 |
|
|
|
2,297 |
|
| Series
3 warrants |
|
|
1,566 |
|
|
|
1,566 |
|
|
|
1,566 |
|
|
|
1,566 |
|
| Unvested
restricted stock units and awards |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
17,152 |
|
| Common
stock warrants February 2023 |
|
|
31,563 |
|
|
|
33,982 |
|
|
|
31,563 |
|
|
|
33,982 |
|
| Underwriter
warrants February 2023 |
|
|
1,933 |
|
|
|
1,933 |
|
|
|
1,933 |
|
|
|
1,933 |
|
| Common
stock private placement warrants June 2023 |
|
|
28,409 |
|
|
|
28,409 |
|
|
|
28,409 |
|
|
|
28,409 |
|
| Placement
agent warrants June 2023 |
|
|
852 |
|
|
|
852 |
|
|
|
852 |
|
|
|
852 |
|
| Common
stock warrants October 2023 |
|
|
354,994 |
|
|
|
— |
|
|
|
354,994 |
|
|
|
706,556 |
|
| Underwriter
warrants October 2023 |
|
|
10,664 |
|
|
|
10,664 |
|
|
|
10,664 |
|
|
|
10,664 |
|
| Placement
agent warrants June 2024 |
|
|
14,142 |
|
|
|
— |
|
|
|
14,142 |
|
|
|
— |
|
| Common
stock warrants June 2024 |
|
|
703,125 |
|
|
|
— |
|
|
|
703,125 |
|
|
|
— |
|
| Common
stock warrants November 2024 |
|
|
2,222,222 |
|
|
|
— |
|
|
|
2,222,222 |
|
|
|
— |
|
| Common
stock registered direct warrants December 2024 |
|
|
1,085,325 |
|
|
|
— |
|
|
|
1,085,325 |
|
|
|
— |
|
| Common
stock PIPE warrants December 2024 |
|
|
673,000 |
|
|
|
— |
|
|
|
673,000 |
|
|
|
— |
|
| Total
anti-dilutive weighted average shares |
|
|
5,144,413 |
|
|
|
94,024 |
|
|
|
5,144,413 |
|
|
|
817,732 |
|
|